Given that the Phase I clinical trial in IPF demonstrated a reduction of senescent cells and SASP within eleven days after a single treatment of D+Q, and improvements in physiological outcomes after 10 weeks (105), we reasoned that a three-month period would provide important feasibility, compliance and efficacy data, as well as potentially reveal other cognitive and biomarker effects useful for designing a larger study
Precision Metered Delivery Each actuation delivers approximately 100 micrograms of the combined peptide formulation, supporting accurate and repeatable administration throughout laboratory studies
The median survivals in the 0-, 1-, 3-, and 5-Gy groups were 836.5 (95% confidence interval (CI) 880804), 846 (95% CI 883709), 659 (95% CI 520743), and 609 (95% CI 531734) days, respectively
Into the heart of milk thistle Milk thistle has a sweet, warming and nourishing action
Nikolova, V.L., et al